Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 20/20 | 0.72 |
| ▸ | RXRB | P28702 | 7/20 | 0.72 |
| ▸ | RXRG | P48443 | 7/20 | 0.72 |
| ▸ | RARB | P10826 | 5/20 | 0.72 |
| ▸ | RARG | P13631 | 4/20 | 0.72 |
| ▸ | RARA | P10276 | 2/20 | 0.72 |
| ▸ | MEN1 | O00255 | 1/20 | 0.72 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.72 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.72 |
| ▸ | ESR1 | P03372 | 1/20 | 0.72 |
| ▸ | PGR | P06401 | 1/20 | 0.72 |
| ▸ | HTR1A | P08908 | 1/20 | 0.72 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.72 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.72 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.72 |
| ▸ | DRD1 | P21728 | 1/20 | 0.72 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.72 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.72 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.72 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7756699 | 0.86 | RXRA (0.78) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL7760712 | 0.86 | RXRA (0.61) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL13846924 | 0.85 | RXRA (0.72) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL4004146 | 0.85 | RXRA (0.72) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL12755164 | 0.84 | RXRA (0.79) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL12181009 | 0.84 | RXRA (0.79) | RXRARXRBRXRGRARBRARG | |
| Bexarotene SCHEMBL9025 | 0.84 | RXRA (1.00) | RXRARXRBRXRGRARBRARG | |
| Bexarotene SCHEMBL29412584 | 0.84 | RXRA (1.00) | RXRARXRBRXRGRARBRARG | |
| Bexarotene SCHEMBL5322954 | 0.84 | RXRA (1.00) | RXRARXRBRXRGRARBRARG | |
| SCHEMBL14068120 | 0.83 | RXRA (0.50) | RXRARXRBRXRGRARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114361717-A | Composite separator and electrochemical device | 珠海冠宇电池股份有限公司 | 2022-04-15 | — | — | CN | claimed |
| US-20230125852-A1 | SEPARATOR AND BATTERY INCLUDING SEPARATOR | ZHUHAI COSMX BATTERY CO., LTD. (CN) | 2023-04-27 | — | — | US | disclosed |
| EP-4156401-A1 | DIAPHRAGM, AND BATTERY COMPRISING SAME | Zhuhai CosMX Battery Co., Ltd. (CN) | 2023-03-29 | — | — | EP | disclosed |
| CN-218498299-U | Diaphragm, roll up core and battery | 珠海冠宇电池股份有限公司 | 2023-02-17 | — | — | CN | disclosed |
| CN-115411456-A | Diaphragm, roll up core and battery | 珠海冠宇电池股份有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-113363575-B | Sulfonic polymer eutectic solid electrolyte and preparation method thereof | 中国科学院青岛生物能源与过程研究所 | 2022-08-26 | — | — | CN | disclosed |
| CN-111613399-B | PTC material and application thereof | 珠海冠宇电池股份有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-114641890-A | Diaphragm and high-voltage battery comprising same | 珠海冠宇电池股份有限公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-114583412-A | Negative pole piece and lithium ion battery comprising same | 珠海冠宇电池股份有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-112615107-B | Microsphere, diaphragm containing microsphere and lithium ion battery containing diaphragm | 珠海冠宇电池股份有限公司 | 2022-04-22 | — | — | CN | disclosed |
| CN-111048722-A | Organic-inorganic composite lithium ion conduction diaphragm, preparation method thereof and lithium-oxygen battery obtained by using same | 河南大学 | 2020-04-21 | — | — | CN | disclosed |
| CN-111029514-A | Diaphragm and high-voltage battery comprising same | 珠海冠宇电池有限公司 | 2020-04-17 | — | — | CN | disclosed |
| US-10546783-B2 | Manufacturing process of element chip and substrate heating apparatus | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2020-01-28 | — | — | US | disclosed |
| US-20190006238-A1 | MANUFACTURING PROCESS OF ELEMENT CHIP AND SUBSTRATE HEATING APPARATUS | PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) | 2019-01-03 | — | — | US | disclosed |
| US-20080297906-A1 | Anisotropic Diffusion Film | TORAY INDUSTRIES, INC. (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080234229-A1 | Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders | AUSPEX PHARMACEUTICALS, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-20080234229-A1 | Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders | AUSPEX PHARMACEUTICALS, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| US-20080234229-A1 | Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders | AUSPEX PHARMACEUTICALS, INC. (US) | 2008-09-25 | — | — | US | disclosed |
| EP-1767962-A1 | ANISOTROPIC DIFFUSION FILM | TORAY INDUSTRIES, INC. (JP) | 2007-03-28 | — | — | EP | disclosed |
| WO-2007022437-A2 | THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER AND METABOLIC DISORDERS | AUSPEX PHARMACEUTICALS, INC. (US) | 2007-02-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234229-A1 | Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders | IGF1R, INSR, BRCA1 | RXRA 494/4885RXRB 487/4885RXRG 526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.